1 / 8

Asthma Therapeutics Market by Drug Class, by Product, by Route of Administration, by Geography, Size, Share, Growth, Gl

The global asthma therapeutics market is majorly segmented into drug classes such as bronchodilators and anti-inflammatories, and combination therapy. The products segment comprises dry powder inhalers, metered-dose inhalers (MDIs), mist inhalers, and nebulizers. In terms of route of administration, this market is further sub-segmented as inhalation,u00a0oralu00a0and parenteral drugs. Combination therapy held the largest market share in the drug class segment due to factors such as the rising prevalence of asthma and patient compliance. Metered-dose inhalers lead the product segment due to factors such as immediate relief in asthma attacks and consistent drug delivery.u00a0

Télécharger la présentation

Asthma Therapeutics Market by Drug Class, by Product, by Route of Administration, by Geography, Size, Share, Growth, Gl

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Asthma Therapeutics Market Asthma Therapeutics Market by Drug Class, by Product, by Route of Administration, by Geography, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027 Know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=18943

  2. Global Asthma Therapeutics Market Market Synopsis: Theglobal asthma therapeutics market size was accounted for around USD 16 billion in 2019 and projected to grow at a significant CAGR of 6 %The global asthma therapeutics market is majorly segmented into drug classes such as bronchodilators and anti-inflammatories, and combination therapy. The products segment comprises dry powder inhalers, metered-dose inhalers (MDIs), mist inhalers, and nebulizers. In terms of route of administration, this market is further sub-segmented as inhalation, oral and parenteral drugs. Combination therapy held the largest market share in the drug class segment due to factors such as the rising prevalence of asthma and patient compliance. Metered-dose inhalers lead the product segment due to factors such as immediate relief in asthma attacks and consistent drug delivery.

  3. Global Asthma Therapeutics Market Research Methoddolgy:

  4. Global Asthma Therapeutics Market Global Asthma Therapeutics Market Segmentation: By Drug Class, 2018–2027 ($ Million) • Anti-inflammatory drugs • Bronchodilators • Combination therapy By Product, 2018–2027 ($ Million) • Dry Powder Inhalers (DPI) • Metered Dose Inhalers (MDI) • Mist Inhaler • Nebulizer

  5. Global Asthma Therapeutics Market Global Asthma Therapeutics Market Segmentation: • By Route of Administration, 2018–2027 ($ Million) • Inhalation • Oral • Parenteral • By Geography, 2018-2027 ($ Million) • North America • Europe • Asia Pacific • Latin America • Middle East and Africa

  6. Global Asthma Therapeutics Market List of Key Companies: • Abbott Laboratories • AstraZeneca • Becton, Dickinson and Company • BoehringerIngelheim GmbH • ChiesiFarmaceutici • Hoffmann-La Roche • GlaxoSmithKline Plc. • Merck& Co., Inc. • Pfizer • Philips Healthcare • Sanofi-Aventis SA • Sunovion Pharmaceuticals, Inc. • Teva Pharmaceutical Industries Ltd.

  7. Global Asthma Therapeutics Market By Region:

  8. Global Asthma Therapeutics Market Media Contact: Company Name: Research CorridorContact Person: Mr. Vijendra SinghEmail: sales@researchcorridor.comContact no: +91 989-368-5690 Follow Us:

More Related